Mid-Size Pharmaceuticals Global Market Report 2025

Description

Mid-sized pharmaceutical companies are characterized by annual revenues ranging from $1 billion to $10 billion. These companies engage in diverse activities such as drug development, niche market targeting, regional presence, partnerships, generic drug manufacturing, and contract manufacturing.

The primary modes of drug development for mid-sized pharmaceutical firms include in-house and outsourced approaches. In-house activities refer to functions conducted internally within the organization by its own employees or departments, rather than being outsourced to external parties or contractors. In the context of mid-sized pharmaceuticals, in-house activities encompass a range of functions such as research and development, manufacturing, quality control, regulatory affairs, sales and marketing, and other operational aspects of the pharmaceutical business. These companies typically offer prescription and over-the-counter medications in various forms, including tablets, capsules, injectables, sprays, and others, catering to the treatment of conditions such as cardiovascular diseases, pain management, diabetes, cancer, and more.

The mid-size pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides mid-size pharmaceuticals market statistics, including the mid-size pharmaceuticals industry's global market size, regional shares, competitors with a mid-size pharmaceuticals market share, detailed mid-size pharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the mid-size pharmaceuticals industry. This mid-size pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mid-size pharmaceuticals market size has grown strongly in recent years. It will grow from $718.71 billion in 2024 to $768.01 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to generic drug market growth, patent expirations of blockbuster drugs, healthcare cost containment measures, biotechnology expansion, and regulatory changes encouraging innovation

The mid-size pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $1002.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a growing shift towards value-based care models, regulatory pathway streamlining, increased health awareness and patient empowerment, demand for generic and biosimilar drugs, emergence of digital therapeutics. Major trends in the forecast period include an increased focus on patient-centric approaches, the adoption of artificial intelligence (AI), global market expansion strategies, environmental sustainability initiatives, telemedicine, and remote patient monitoring.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the mid-size pharmaceuticals market in the future. Chronic diseases, also referred to as non-communicable diseases, are long-term medical conditions that necessitate ongoing management and treatment, resulting in a high demand for medications. Mass spectrometry techniques are employed for the identification, quantification, and analysis of biomarkers and metabolites related to chronic diseases. An increase in the prevalence of these conditions will further support the growth of the mid-size pharmaceuticals market. For example, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that non-communicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global deaths. Hence, the rising prevalence of chronic diseases is propelling the growth of the mid-size pharmaceuticals market.

The increasing expenditure on healthcare is expected to contribute to the growth of the mid-size pharmaceutical market. Healthcare encompasses the organized provision of medical care, preventive services, diagnostic testing, treatment, and support services, with the overarching goal of maintaining and improving overall health. Higher healthcare spending often translates into increased investment in research and development within the pharmaceutical industry. Mid-sized pharmaceutical companies stand to benefit from this heightened investment, enabling them to develop and introduce new drugs to the market. For example, data from the Economic Survey of 2022 reveals that India's public expenditure on healthcare reached 2.1% of GDP in 2021-22. Furthermore, a survey conducted by Willis Towers Watson Public Limited Company indicates a global average growth in healthcare benefit costs, which increased to 8.8% in 2022 and is projected to further rise to 10% in 2023. This increased healthcare expenditure is poised to drive the growth of the mid-size pharmaceutical market.

Technology advancements stand out as a prominent trend gaining momentum in the mid-size pharmaceuticals market. Leading companies in this market are leveraging technology to maintain their competitive positions. For example, in May 2023, Google Cloud, the suite of cloud computing services offered by Google, introduced A.I.-powered tools aimed at accelerating drug discovery and precision medicine. One such tool, the Target and Lead Identification Suite, assists businesses in anticipating and understanding protein structure, a critical aspect of drug research. Another tool, the Multiomics Suite, enables researchers to ingest, store, analyze, and share large volumes of genetic data.

Major companies in the mid-size pharmaceuticals sector are strategically focusing on product development and launches, particularly in the area of precision medicine platforms, to sustain their market positions. A precision medicine platform is an advanced technology or system designed to customize medical treatment and interventions based on the specific characteristics of individual patients. In February 2023, C4X Discovery Holdings PLC, a mid-size pharmaceutical company based in the UK, unveiled its innovative precision medicine platform, PatientSeek. This platform identifies patients who are most likely to benefit from a specific medication based on their genetic makeup. The launch of PatientSeek follows successful validation in patient stratification, where a subgroup of patients responding positively to treatment was identified during a retrospective analysis of a Phase 3 clinical trial for Parkinson's disease. This development showcases the potential of precision medicine in optimizing treatment outcomes by leveraging genetics for targeted and effective medication strategies.

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. This strategic acquisition enables Sun Pharmaceutical Industries Limited to incorporate Concert's innovative medicines, including deuruxolitinib-a novel, deuterated, oral JAK1/2 inhibitor-into its pipeline. Deuruxolitinib holds potential for treating adult patients with moderate to severe alopecia areata, expanding Sun Pharmaceutical's portfolio and strengthening its position in the mid-size pharmaceuticals market. Concert Pharmaceuticals Inc., the acquired entity, is a US-based late-stage clinical mid-sized biopharmaceutical company dedicated to developing innovative medicines with unique therapeutic properties.

Major companies operating in the mid-size pharmaceuticals market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.

North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mid-size pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mid-size pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mid-sized pharmaceuticals market consists of revenues earned by entities providing pharmaceutical services such as drug development, research activities, generic drug manufacturing, and contract manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The mid-sized pharmaceuticals market consists of the sales of goods such as prescription drugs, over-the-counter medications, generic drugs, and other pharmaceutical products targeting specific therapeutic areas or niche markets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mid-Size Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mid-size pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mid-size pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mid-size pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Development Type: In-House; Outsource
2) By Type: Prescription; Over The Counter
3) By Formulation: Tablets; Capsules; Injectables; Sprays; Other Formulations
4) By Application: Cardiovascular Diseases; Pain Management; Diabetes; Cancer; Other Conditions
Subsegments:
1) By In-House: Research And Development (R&D) Departments; Clinical Trials Management
2) By Outsource: Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs)
Companies Mentioned: Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co Ltd.; Astellas Pharma Inc.; Daiichi Sankyo Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25113

1. Executive Summary

2. Mid-Size Pharmaceuticals Market Characteristics

3. Mid-Size Pharmaceuticals Market Trends And Strategies

4. Mid-Size Pharmaceuticals Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Mid-Size Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Mid-Size Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mid-Size Pharmaceuticals Market Growth Rate Analysis
5.4. Global Mid-Size Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mid-Size Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mid-Size Pharmaceuticals Total Addressable Market (TAM)

6. Mid-Size Pharmaceuticals Market Segmentation

6.1. Global Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In-House
Outsource
6.2. Global Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription
Over The Counter
6.3. Global Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injectables
Sprays
Other Formulations
6.4. Global Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Other Conditions
6.5. Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of In-House, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research And Development (R&D) Departments
Clinical Trials Management
6.6. Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of Outsource, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)

7. Mid-Size Pharmaceuticals Market Regional And Country Analysis

7.1. Global Mid-Size Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mid-Size Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mid-Size Pharmaceuticals Market

8.1. Asia-Pacific Mid-Size Pharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mid-Size Pharmaceuticals Market

9.1. China Mid-Size Pharmaceuticals Market Overview
9.2. China Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mid-Size Pharmaceuticals Market

10.1. India Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mid-Size Pharmaceuticals Market

11.1. Japan Mid-Size Pharmaceuticals Market Overview
11.2. Japan Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mid-Size Pharmaceuticals Market

12.1. Australia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mid-Size Pharmaceuticals Market

13.1. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mid-Size Pharmaceuticals Market

14.1. South Korea Mid-Size Pharmaceuticals Market Overview
14.2. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mid-Size Pharmaceuticals Market

15.1. Western Europe Mid-Size Pharmaceuticals Market Overview
15.2. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mid-Size Pharmaceuticals Market

16.1. UK Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mid-Size Pharmaceuticals Market

17.1. Germany Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mid-Size Pharmaceuticals Market

18.1. France Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mid-Size Pharmaceuticals Market

19.1. Italy Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mid-Size Pharmaceuticals Market

20.1. Spain Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mid-Size Pharmaceuticals Market

21.1. Eastern Europe Mid-Size Pharmaceuticals Market Overview
21.2. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mid-Size Pharmaceuticals Market

22.1. Russia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mid-Size Pharmaceuticals Market

23.1. North America Mid-Size Pharmaceuticals Market Overview
23.2. North America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mid-Size Pharmaceuticals Market

24.1. USA Mid-Size Pharmaceuticals Market Overview
24.2. USA Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mid-Size Pharmaceuticals Market

25.1. Canada Mid-Size Pharmaceuticals Market Overview
25.2. Canada Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mid-Size Pharmaceuticals Market

26.1. South America Mid-Size Pharmaceuticals Market Overview
26.2. South America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mid-Size Pharmaceuticals Market

27.1. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mid-Size Pharmaceuticals Market

28.1. Middle East Mid-Size Pharmaceuticals Market Overview
28.2. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mid-Size Pharmaceuticals Market

29.1. Africa Mid-Size Pharmaceuticals Market Overview
29.2. Africa Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mid-Size Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Mid-Size Pharmaceuticals Market Competitive Landscape
30.2. Mid-Size Pharmaceuticals Market Company Profiles
- 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Otsuka Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Daiichi Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Mid-Size Pharmaceuticals Market Other Major And Innovative Companies

31.1. Alexion Pharmaceuticals Inc.
31.2. UCB S.A.
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Eisai Co. Ltd.
31.5. Wuxi AppTec co. Ltd.
31.6. Les Laboratoires Servier S.A.
31.7. Hospira Inc.
31.8. Perrigo Co Plc
31.9. Aurobindo Pharma Lmited.
31.10. Cipla Limited
31.11. Hikma Pharmaceuticals
31.12. Endo International plc
31.13. Taisho Pharmaceutical Holdings Co. Ltd.
31.14. BioMarin Pharmaceutical Inc.
31.15. Mallinckrodt Plc

32. Global Mid-Size Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mid-Size Pharmaceuticals Market

34. Recent Developments In The Mid-Size Pharmaceuticals Market

35. Mid-Size Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Mid-Size Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
35.2 Mid-Size Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
35.3 Mid-Size Pharmaceuticals Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer